Clinical trial

Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery

NCT01880827

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-01-01

PhasePHASE1

Study timeline

Study start (unknown)2013-01-01Date precision: month

Registry last updated2021-10-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Obesityunresolved

Interventions

Roux-en-YPROCEDURE

GIP-infusionDRUG

GLP-1DRUG

MMSDRUG

Sleeve gastrectomyPROCEDURE

Sponsors & collaborators

Turku University Hospitallead sponsor

Lund Universitycollaborator

Mapped research locations

TurkuFinland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01880827 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.